Erudio Bio, Inc.
Intro
Erudio Bio, Inc. is transforming the economics of medicine with our innovative Versatile Smart Assay (VSA), a cutting-edge semiconductor-based multiplexed instrument platform. Our technology enables comprehensive biomarker testing from a single biological sample, facilitating precise diagnoses and reducing the risk of missed or delayed disease identification. Utilizing our patented dynamic force spectroscopy, Erudio's VSA significantly reduces false positives and achieves unparalleled accuracy by measuring the strength of biomarker-antibody binding. This empowers healthcare providers to detect diseases earlier, saving countless lives and preventing unnecessary suffering.

Recent Posts
- Press Release - Erudio Bio Announces Dual Breakthrough in Precision Diagnostics @ 14-Jan-2025
- Erudio's Intellectual Property @ 01-Mar-2024
- Erudio Bio Announces Partnership with Shanghai General Hospital for Ocular Biomarker Research @ 06-Feb-2024